Fludeoxyglucose (18F)
- Generic Name
- Fludeoxyglucose (18F)
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11FO5
- CAS Number
- 63503-12-8
- Unique Ingredient Identifier
- 0Z5B2CJX4D
- Background
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection.
- Indication
The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.
...
- Associated Conditions
- Cancer, Coronary Artery Disease (CAD), Epileptic seizure, Left Ventricular Dysfunction
- Associated Therapies
- -
Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study
- First Posted Date
- 2016-02-10
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 20
- Registration Number
- NCT02678884
- Locations
- 🇨🇦
University Health Network, Princess Margaret Cancer Center, Toronto, Ontario, Canada
18F-FSPG PET/CT for Cancer Patients on Therapy
- Conditions
- Interventions
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Andrei Iagaru
- Target Recruit Count
- 7
- Registration Number
- NCT02599194
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
- Conditions
- Interventions
- First Posted Date
- 2015-05-27
- Last Posted Date
- 2020-01-14
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 47
- Registration Number
- NCT02455453
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2015-04-29
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 4
- Registration Number
- NCT02429804
- Locations
- 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States
Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- First Posted Date
- 2015-04-01
- Last Posted Date
- 2022-10-28
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT02405078
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
- Conditions
- Interventions
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 29
- Registration Number
- NCT02149173
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Links Between Inflammation and Cardiometabolic Diseases
- Conditions
- Interventions
- First Posted Date
- 2013-09-04
- Last Posted Date
- 2024-12-02
- Target Recruit Count
- 150
- Registration Number
- NCT01934660
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
- Conditions
- Interventions
- First Posted Date
- 2013-07-01
- Last Posted Date
- 2014-09-29
- Lead Sponsor
- Avid Radiopharmaceuticals
- Target Recruit Count
- 34
- Registration Number
- NCT01890343
- Locations
- 🇬🇧
Research Site, Manchester, United Kingdom
The Differential Diagnosis of Parkinson's Disease and Parkinsonism by Positron-emission Tomography
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2013-11-13
- Lead Sponsor
- Chang Gung Memorial Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT01824056
- Locations
- 🇨🇳
Chang Gung Memory Hpspital, Taoyuan, Taiwan
18F-FDG PET/CT for IgG4-Related Disease
- First Posted Date
- 2012-08-15
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Peking Union Medical College Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01665196
- Locations
- 🇨🇳
Peking Union Medical College Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.